BioNexus Gene Lab Corp - Common stock (BGLC)
0.2875
+0.0025 (0.88%)
Bionexus Gene Lab Corp is a biotechnology company focused on the development and commercialization of innovative genomic solutions and technologies
The company specializes in harnessing the power of genetic research to create advanced diagnostic tools and therapeutic products aimed at improving health outcomes. Through its cutting-edge platforms, Bionexus aims to enhance our understanding of genetic diseases and facilitate precision medicine, thereby contributing to more effective treatments and personalized healthcare solutions.
Frequently Asked Questions
Is BioNexus Gene Lab Corp - Common stock publicly traded?
Yes, BioNexus Gene Lab Corp - Common stock is publicly traded.
What exchange does BioNexus Gene Lab Corp - Common stock trade on?
BioNexus Gene Lab Corp - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for BioNexus Gene Lab Corp - Common stock?
The ticker symbol for BioNexus Gene Lab Corp - Common stock is BGLC on the Nasdaq Stock Market
What is the current price of BioNexus Gene Lab Corp - Common stock?
The current price of BioNexus Gene Lab Corp - Common stock is 0.2875
When was BioNexus Gene Lab Corp - Common stock last traded?
The last trade of BioNexus Gene Lab Corp - Common stock was at 3:45 pm EDT on March 24th, 2025